Compare stocks

Evotec SE is a biotechnology company specializing in drug discovery and development solutions across various therapeutic areas, including neuroscience, oncology, and metabolic diseases. The company provides integrated services and innovative research through its platforms, such as EVOequity and INDiGO, which accelerate drug candidates from discovery to commercialization. Founded in 1993, Evotec is headquartered in Hamburg, Germany, and operates worldwide with multiple research sites in Europe and the United States. Through strategic collaborations with pharmaceutical and academic institutions, Evotec enhances its research capabilities and expands its global reach, leveraging advanced technologies and a collaborative approach to drive innovation in drug development.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.